HIV DNA vaccine

Lentiviral packaging constructs

Genome of the HIV-1 inter-subtype (C/B') and use thereof

Therapeutic peptides for the treatment of metastatic cancer

Modified Vaccinia Ankara virus variant

Polypeptide antagonists of HIV-1 Tat protein

Membrane-permeant peptide complexes for treatment of sepsis

Methods and compositions for impairing multiplication of HIV-1

Fusion proteins of non-attenuated HIV regulatory/accessory proteins

Method for identification and development of therapeutic agents

Ferritin fusion proteins for use in vaccines and other applications

Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

Non-immunosuppressive immunogenic or vaccine composition comprising a mutated E7 protein of the HPV-16 virus

Peptide-enhanced transfections

Polypeptide transduction and fusogenic peptides

MAGE-A3/HPV 16 peptide vaccines for head and neck cancer

Compositions and methods for delivery of genetic material

Epitopes of human immunodeficiency virus-1

Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

HIV TEV compositions and methods of use

Technology of intracellular delivery of DNA oligonucleotides to improve drug activity

Membrane-permeant peptide complexes for treatment of sepsis

Method of inducing an enhanced immune response against hiv

Advanced cell-transducing transport domain-target protein-transport domain fusion protein and uses thereof

Compositions and methods for inhibiting cell senescence and hyperproliferative disorders

Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses

Vaccine

Genetic constructs and compositions comprising RRE and CTE and uses thereof

Regulated nucleic acid expression system

Cellular immunity test with peptides fixed on a solid support

Identification of new CD8 epitopes from HIV-1 proteins

Intracellular delivery of small molecules, proteins, and nucleic acids

Vaccines against hiv-1 tat protein to generate neutralizing antibodies

Mutated hpv-16e7 polypeptide, pharmaceutical composition comprising it and its preparation process

Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity

Peptide delivery

Functional fragments of HIV-1 VPR protein and methods of using the same

Methods of intracellular peptide delivery

Werner's syndrome helicase as a target for anti -HIV/AIDS therapy

Screening methods for the identification of inhibitors of human immunodeficiency virus (HIV) viral protein R (Vpr) binding to the adenine nucleotide translocator (ANT)

Compositions comprising human immunodeficiency virus Tat adsorbed to the surface of anionic nanoparticles

Methods and formulations comprising agonists and antagonists of nuclear hormone receptors

HIV antisense proteins

Na+ and CI-coupled transport system for endogenous opioid peptides

Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses

Antigen delivery vectors and constructs

Membrane-anchored beta2 microglobulin covalently linked to mhc class 1 peptide epitopes

Polycistronic HIV vector constructs

Modified Vaccinia Ankara virus variant

Recombinant lentivirus encoding modified GP 120 signal sequences

Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions

Novel use

Double transdominant fusion gene and protein

HIV antisense proteins

Methods and compositions for impairing multiplication of HIV-1

Tat-based tolerogen compositions and methods of making and using same

Methods and compositions comprising bacteriophage nanoparticles

Tat-based vaccine compositions and methods of making and using same

Fusion protein of hiv regulatory/accessory proteins

Reference clones and sequences for non-subtype B isolates of human immunodeficiency virus type 1

Variant Tat proteins and methods for use thereof

Polynucleotide vaccines expressing codon optimized HIV-1 Nef and modified HIV-1 Nef

Modified Vaccinia Ankara virus variant and cultivation method

Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof

Tat-based immunomodulatory compositions and methods for their discovery and use

Preventive and therapeutic aids vaccines

Method of inhibiting influenza infection with antiviral peptides

Non-pathogenic strains of HIV-1

Methods of generating a humoral immune response against human immunodeficiency virus (HIV) comprising administering Nef apoptotic motif-containing polypeptide-conjugates

HIV-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof

HIV pharmaccines

High-throughput assay for virus entry and drug screening

Hiv-1 virus tat-protein mutants

CD8 epitope from HIV-1 protein Vpu

HIV-encoded chemoattractant

PTD-modified proteins

Method and kit for detection of tat protein with anti-tat oyi antibodies

Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications

Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv

Targeted particles and methods of using the same

HIV-1 peptide, antigen, immunogenic composition, diagnostic method and immunoassay kit

Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same

Compositions and methods for peptide-assisted transfection

Compositions of antigens bound to HIV-1 Tat, fragments or derivatives thereof

Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination

Fusion proteins comprising HIV-1 Tat and/or Nef proteins

Hematopoietic stem cell gene therapy

Attenuated HIV strains and uses thereof

Novel chimeric rev, tat, and nef antigens

Viral uptake into cells and tissues

HIV antisense proteins

Non-ionically bound constructs, and compositions and kits comprising domains